Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Aug;39(8):2485-2486.
doi: 10.1007/s10067-020-05247-5. Epub 2020 Jun 18.

Colchicine as a possible therapeutic option in COVID-19 infection

Affiliations
Comment

Colchicine as a possible therapeutic option in COVID-19 infection

Rafael Parra-Medina et al. Clin Rheumatol. 2020 Aug.
No abstract available

PubMed Disclaimer

Comment on

References

    1. Cumhur Cure M, Kucuk A, Cure E (2020) Colchicine may not be effective in COVID-19 infection; it may even be harmful? Clin Rheumatol:12–13 - PMC - PubMed
    1. Nuki G. Colchicine: its mechanism of action and efficacy in crystal-induced inflammation. Curr Rheumatol Rep. 2008;10(3):218–227. doi: 10.1007/s11926-008-0036-3. - DOI - PubMed
    1. Qin C, Zhou L, Hu Z, Zhang S, Yang S, Tao Y et al (2020) Dysregulation of immune response in patients with COVID-19 in Wuhan, China. Clin Infect Dis - PMC - PubMed
    1. Martínez GJ, Celermajer DS, Patel S. The NLRP3 inflammasome and the emerging role of colchicine to inhibit atherosclerosis-associated inflammation. Atherosclerosis. 2018;269:262–271. doi: 10.1016/j.atherosclerosis.2017.12.027. - DOI - PubMed
    1. Conti P, Ronconi G, Caraffa A, Gallenga C, Ross R, Frydas I et al (2020) Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by Coronavirus-19 (COVI-19 or SARS-CoV-2): anti-inflammatory strategies. J Biol Regul Homeost Agents 34(2) - PubMed

LinkOut - more resources